These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3390914

  • 1. Sialic acid in sickle cell disease.
    Ekeke GI, Ibeh GO.
    Clin Chem; 1988 Jul; 34(7):1443-6. PubMed ID: 3390914
    [Abstract] [Full Text] [Related]

  • 2. Erythrocyte sialic acid in human sickle-cell disease.
    Onyemelukwe GC, Esievo KA, Kwanashie CN, Kulkarni AG, Obinechie EN.
    J Comp Pathol; 1987 Mar; 97(2):143-7. PubMed ID: 3597847
    [Abstract] [Full Text] [Related]

  • 3. Membrane components in the red cells of patients with sickle cell anemia. Relationship to cell aging and to irreversibility of sickling.
    Westerman MP, Diloy-Puray M, Streczyn M.
    Biochim Biophys Acta; 1979 Oct 19; 557(1):149-55. PubMed ID: 549632
    [Abstract] [Full Text] [Related]

  • 4. Sialic acid content of erythrocytes in normal individuals and patients with certain hematologic disorders.
    Aminoff D, Anderson J, Dabich L, Gathmann WD.
    Am J Hematol; 1980 Oct 19; 9(4):381-9. PubMed ID: 7211833
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preservation of deformability (filterability) of sickle cells by BW12C during progressive deoxygenation.
    Kenny MW, Stuart J.
    Br J Haematol; 1983 Nov 19; 55(3):465-71. PubMed ID: 6639888
    [Abstract] [Full Text] [Related]

  • 8. Sickling-induced binding of immunoglobulin to sickle erythrocytes.
    Green GA, Kalra VK.
    Blood; 1988 Mar 19; 71(3):636-9. PubMed ID: 3278749
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease.
    Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW.
    J Clin Invest; 1980 Jan 19; 65(1):154-60. PubMed ID: 7350195
    [Abstract] [Full Text] [Related]

  • 12. Reconstitution of the masking effect of sialic acid groups on sialidase-treated erythrocytes by the action of sialyltransferases.
    Kelm S, Shukla AK, Paulson JC, Schauer R.
    Carbohydr Res; 1986 Jun 01; 149(1):59-64. PubMed ID: 3089604
    [Abstract] [Full Text] [Related]

  • 13. Sickling and Vinblastine.
    Ricci G, Zavagli G.
    Biomed Pharmacother; 1983 Jun 01; 37(2):85-7. PubMed ID: 6616035
    [Abstract] [Full Text] [Related]

  • 14. Surface-associated sialic acid is an immunological adjuvant.
    van Dijk H, Rademaker PM, Klerx JP, Snippe H, Willers JM.
    Immunol Lett; 1985 Jun 01; 11(5-6):337-42. PubMed ID: 4093153
    [Abstract] [Full Text] [Related]

  • 15. Effects of trifluoperazine and membrane-bound sialic acid on 45Ca2+ uptake into erythrocytes.
    Günther T, Höllriegl V, Fehlinger R.
    J Trace Elem Electrolytes Health Dis; 1988 Mar 01; 2(1):15-8. PubMed ID: 2980786
    [Abstract] [Full Text] [Related]

  • 16. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
    Ren H, Ghebremeskel K, Okpala I, Ugochukwu CC, Crawford M, Ibegbulam O.
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan 01; 74(1):1-6. PubMed ID: 16314081
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Erythrocyte membrane lipid reorganization during the sickling process.
    Chiu D, Lubin B, Shohet SB.
    Br J Haematol; 1979 Feb 01; 41(2):223-34. PubMed ID: 427032
    [Abstract] [Full Text] [Related]

  • 19. The erythrocyte membranes in beta-thalassemia. Lower sialic acid levels in glycophorin.
    Kahane I, Ben-Chetrit E, Shifter A, Rachmilewitz EA.
    Biochim Biophys Acta; 1980 Feb 15; 596(1):10-7. PubMed ID: 7353002
    [Abstract] [Full Text] [Related]

  • 20. Effects of valinomycin, A23187 and repetitive sickling on irreversible sickle cell formation.
    Westerman MP, Allan D.
    Br J Haematol; 1983 Mar 15; 53(3):399-409. PubMed ID: 6402002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.